Classical Parkinson disease versus Parkinson complex – Reflections against staging and in favour of heterogeneity

No abstract is available for this paper.

• Publication year

  2007

• Venue

  European Journal of Neurology

• Publication date

  2007-07-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1111/j.1468-1331.2007.01853.xPMID 17594326
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cell Therapy for Parkinson's Disease: Only Young Onset Patients Allowed? Reflections about the Results of Recent Clinical Trials with Cell Therapy and the Progression of Parkinson's Disease

  2006cited by this paper
• Neuropathologic findings in essential tremor

  2006cited by this paper
• The parkinson's complex: Parkinsonism is just the tip of the iceberg

  2006influential reference
• Critical appraisal of brain pathology staging related to presymptomatic and symptomatic cases of sporadic Parkinson's disease.

  2006cited by this paper
• Predicting Parkinson’s disease: worthwhile but are we there yet?

  2006cited by this paper
• Proteasomal dysfunction in sporadic Parkinson's disease

  2006cited by this paper
• Alpha-synuclein pathology in the spinal cords of neurologically asymptomatic aged individuals.

  2006cited by this paper
• Rapid-eye-movement sleep behaviour disorder and neurodegenerative diseases.

  2006cited by this paper
• Association of olfactory dysfunction with incidental Lewy bodies

  2006cited by this paper
• Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study.

  2006cited by this paper
• Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology.

  2006influential reference
• Potential early markers of Parkinson disease in idiopathic REM sleep behavior disorder

  2006cited by this paper
• The diagnosis of Parkinson's disease.

  2006cited by this paper
• Lewy Bodies in Progressive Supranuclear Palsy Represent an Independent Disease Process

  2006cited by this paper
• Parkinson's disease: A broken nosology

  2005cited by this paper
• New ideas on the origin of L-dopa-induced dyskinesias: age, genes and neural plasticity.

  2005cited by this paper
• α-synuclein pathology does not predict extrapyramidal symptoms or dementia

  2005cited by this paper
• Sydney multicenter study of Parkinson's disease: Non‐L‐dopa–responsive problems dominate at 15 years

  2005cited by this paper
• α‐Synuclein pathology does not predict extrapyramidal symptoms or dementia

  2005cited by this paper
• Microglial activation and dopamine terminal loss in early Parkinson's disease

  2005cited by this paper
• [Utility of new tools in the diagnosis of Parkinson's disease: need for regulation].

  2005cited by this paper
• Closed doors and false expectations: cell-based therapies for PD.

  2004cited by this paper
• Idiopathic hyposmia as a preclinical sign of Parkinson's disease

  2004cited by this paper
• Lewy body-related alpha-synucleinopathy in the aged human brain.

  2004cited by this paper
• The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study.

  2004cited by this paper
• Lewy body-related α-synucleinopathy in the aged human brain

  2004cited by this paper
• Combination of 'idiopathic' REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT.

  2004cited by this paper
• Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease

  2004cited by this paper
• Detection of presymptomatic Parkinson's disease: Combining smell tests, transcranial sonography, and SPECT

  2004cited by this paper
• Time to move beyond nigrostriatal dopamine deficiency in Parkinson's disease

  2004cited by this paper
• Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL‐PET study

  2003cited by this paper
• Staging of brain pathology related to sporadic Parkinson's disease.

  2003influential reference
• Tremor in Parkinson’s disease and serotonergic dysfunction

  2003cited by this paper
• Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease.

  2003cited by this paper
• Tremor in Parkinson's disease and serotonergic dysfunction An 11 C-WAY 100635 PET study

  2003cited by this paper
• Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases.

  2003cited by this paper
• Parkinson's Disease Mechanisms and Models

  2003cited by this paper
• Parkinson's disease: piecing together a genetic jigsaw.

  2003cited by this paper
• The diagnosis of Parkinson's disease.

  2003cited by this paper
• The heterogeneity of idiopathic Parkinson's disease

  2002cited by this paper
• Olfactory function in idiopathic Parkinson's disease (IPD): results from cross-sectional studies in IPD patients and long-term follow-up of de-novo IPD patients

  2002cited by this paper
• 3-OMD and homocysteine plasma levels in parkinsonian patients

  2002cited by this paper
• Cell therapy for Parkinson's disease.

  2001cited by this paper
• Lewy body–type degeneration in cardiac plexus in Parkinson’s and incidental Lewy body diseases

  1999cited by this paper
• Measuring the rate of progression and estimating the preclinical period of Parkinson’s disease with [18F] dopa PET

  1999cited by this paper
• Measuring the rate of progression and estimating the preclinical period of Parkinson’s disease with [18F]dopa PET

  1998cited by this paper
• Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder

  1996cited by this paper
• Ageing and Parkinson's disease: substantia nigra regional selectivity.

  1991cited by this paper
• Mitochondrial Complex I Deficiency in Parkinson's Disease

  1989cited by this paper
• Parkinson's disease and megacolon

  1987cited by this paper
• The heterogeneity of Parkinson's disease

  1985cited by this paper

• Neuropathology of incidental Lewy body & prodromal Parkinson’s disease

  2023cites this paper
• Insulin resistance and Parkinson’s disease

  2020cites this paper
• Neurochemical Aspects of Lewy Body Dementia

  2019cites this paper
• The enteric nervous system in PD: gateway, bystander victim, or source of solutions

  2018cites this paper
• Living with Parkinsonism: Does dance help improve the quality of movement, functions and everyday activities?

  2016cites this paper
• Plasma antioxidant status and motor features in de novo Chinese Parkinson's disease patients

  2015cites this paper
• Is Cell Death Primary or Secondary in the Pathophysiology of Idiopathic Parkinson’s Disease?

  2015cites this paper
• Energy metabolism and Protein synthesis in Parkinson's disease and Dementia with Lewy Bodies

  2015influential citation
• The electrophysiological impact of oligomeric alpha-Synuclein on thick-tufted layer 5 pyramidal neurons in the neocortex of mice

  2015cites this paper
• Morbus Parkinson – A synaptic disorder?

  2014cites this paper
• Causes and Consequences of Degeneration of the Dorsal Motor Nucleus of the Vagus Nerve in Parkinson's Disease

  2014cites this paper
• Change in Plasma Levels of Amino Acid Neurotransmitters and its Correlation with Clinical Heterogeneity in Early Parkinson's Disease Patients

  2013cites this paper
• Alpha-synuclein in the neurodegenerative mechanisms of Parkinson's disease and dementia with Lewy bodies

  2012influential citation
• Inflammation and α-Synuclein’s Prion-like Behavior in Parkinson's Disease—Is There a Link?

  2012cites this paper
• Mathematical Models: Interactions Between Serotonin and Dopamine in Parkinson’s Disease

  2011cites this paper
• The synaptic pathology of α-synuclein aggregation in dementia with Lewy bodies, Parkinson’s disease and Parkinson’s disease dementia

  2010cites this paper
• Pathogenesis of PD: Missing the point

  2010cites this paper
• Evidence against a reliable staging system of α‐synuclein pathology in Parkinson's disease

  2009cites this paper
• [Neuroprotection in Parkinson's disease: analysis though group of experts' methodology].

  2009cites this paper
• Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction

  2009cites this paper
• [Onset of dopaminergic therapy in Parkinson's disease: six good reasons not to delay it].

  2008cites this paper
• A critical reappraisal of current staging of Lewy-related pathology in human brain

  2008cites this paper
• [If I were to wake up clumsy and shaking (10 years later)].

  2008cites this paper
• Imaging β-amyloid burden in aging and dementia

  2007cites this paper
• Causes of parkinson ’ s Disease Genetic

  year unknowncites this paper